Emyria Limited (ASX:EMD)
Australia · Delayed Price · Currency is AUD 0.0520
-0.0010 (-1.89%)
At close: Dec 18, 2025
Emyria Market Cap
Emyria has a market cap or net worth of 41.01 million as of December 19, 2025. Its market cap has increased by 174.26% in one year.
Market Cap
41.01M
Enterprise Value
38.06M
Revenue
1.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since February 12, 2020, Emyria's market cap has increased from 26.67M to 41.01M, an increase of 53.80%. That is a compound annual growth rate of 7.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 41.82M | 167.03% |
| Dec 30, 2024 | 15.66M | -17.86% |
| Dec 29, 2023 | 19.06M | -61.44% |
| Dec 30, 2022 | 49.44M | -53.29% |
| Dec 31, 2021 | 105.86M | 410.23% |
| Dec 31, 2020 | 20.75M | -22.19% |
| Feb 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.64B |
| Pro Medicus | 22.94B |
| Cochlear | 16.92B |
| Sonic Healthcare | 11.13B |
| Ramsay Health Care | 7.87B |
| Ansell | 5.03B |
| Telix Pharmaceuticals | 3.97B |
| Mesoblast | 3.59B |